Monthly News Roundup - October 2016

Merck ’s Zinplava Approved to Fend Off Return of Clostridium Difficile Zinplava (bezlotoxumab) has been FDA-approved to reduce the recurrence of Clostridium difficile infection (CDI) in adults who are receiving antibacterial drug treatment for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news